M&A Deal Summary |
|
|---|---|
| Date | 2008-06-04 |
| Target | Alltel |
| Sector | Communications |
| Buyer(s) | Verizon Communications |
| Sellers(s) |
TPG
Goldman Sachs Merchant Banking |
| Deal Type | Add-on Acquisition |
| Deal Value | 28.1B USD |
| Advisor(s) | Wachtell, Lipton, Rosen & Katz (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Communications |
| Employees | 130,100 |
| Revenue | 136.8B USD (2022) |
Verizon Communications is a provider of communications, information, and entertainment products and services to consumers, businesses and governmental agencies. Verizon offers voice, data and video services and solutions on wireless and wireline networks that are designed to meet customers’ demand for mobility, network connectivity, security and control. Verizon dates back to 1983 and is based in New York City. Verizon Communications was founded in 1983 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 34 |
| Sector (Communications) | 5 of 13 |
| Type (Add-on Acquisition) | 4 of 28 |
| State (Arkansas) | 1 of 1 |
| Country (United States) | 6 of 32 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 2 of 15 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-07-30 |
Rural Cellular
Alexandria, Minnesota, United States Rural Cellular Corporation provides wireless communication services under the Unicel brand to Central, Midwest, Northeast, South and Northwest territories located in 15 states. |
Buy | $2.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-01-09 |
Alltel
Little Rock, Arkansas, United States Alltel Corp. is an owner and operator of a wireless network and has approximately 12 million wireless customers, both individuals and businesses. Alltel owns a majority interest in wireless operations in more than 100 metropolitan service areas and a majority interest in more than 200 rural service areas. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 137.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.
| DEAL STATS | # |
|---|---|
| Overall | 54 of 245 |
| Sector (Communications) | 8 of 14 |
| Type (Add-on Acquisition) | 23 of 89 |
| State (Arkansas) | 1 of 2 |
| Country (United States) | 39 of 182 |
| Year (2008) | 5 of 9 |
| Size (of disclosed) | 1 of 71 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-05-07 |
Albireo
Boston, Massachusetts, United States Albireo is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase III trial in ALGS, an ongoing Phase III study in biliary atresia, as well as Open-label Extension (OLE) studies for PFIC and ALGS. The company has also completed a Phase I clinical trial for A3907 to advance development in adult cholestatic liver disease, with IND-enabling studies progressing with A2342 for viral and cholestatic liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-06-22 |
Bank Thai Public Company Limited
Thailand Bank Thai Public Company Ltd. provides various financial and banking services for corporate and individual customers in Thailand. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1986 |
| PE ASSETS | 155.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Goldman Sachs Merchant Banking Division is the investment arm of Goldman Sachs. The primary corporate investment group within the Merchant Banking Division is Goldman Sachs' direct investment arm. GS's direct investment arm consists of GS Capital Partners, GS Mezzanine Partners, and GS Growth Partners. GS Capital Partners is the direct corporate equity investment group which seeks LBO, recapitalization, and growth investments to help fund acquisitions, expansions, recapitalizations, restructurings, buyouts, and take privates. GS Capital Partners looks to invest between $50 and $800 million in opportunities in North/South America, Europe, Asia. GS Mezzanine Partners is the junior capital arm of Goldman Sachs. GS Mezzanine looks to invest between $200 million and and $800 million in transactions valued up to $10 billion. Investment proceeds are used to fund leveraged buyouts, expansion financings, recapitalizations, acquisitions, and restructurings. GS Growth looks to invest in growth equity transactions. The unit seeks to commit $20 to $200 million per investment. Other units within GS's merchant banking division include Real Estate, Infrastructure, and Urban Investments. Goldman Sachs Merchant Banking Division is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 108 |
| Sector (Communications) | 5 of 8 |
| Type (Add-on Acquisition) | 2 of 36 |
| State (Arkansas) | 1 of 1 |
| Country (United States) | 10 of 77 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-04-15 |
Lanx
Broomfield, Colorado, United States Lanx is a medical device company that develops and markets innovative surgical implants and biological products for use in spinal surgery. Lanx was founded in 2003 and is based in Broomfield, Colorado. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-01 |
The Xella Group
Duisburg, Germany The Xella Group is an international solution providers in the field of building and insulation materials. Xella is the parent company of such well-known brands as Ytong, Silka, Hebel, and Multipor, and is one of the pioneers in digitally supported construction processes with its digital planning service blue.sprint. |
Buy | €1.6B |
